Emami Q1 FY27: Revenue up 15% YoY but consolidated PAT slips 15%
EMAMILTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Smallcap 250 and 3.4 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue rose 15% YoY to Rs 1,03,921 lacs in Q1 FY27, but PAT fell 15% to Rs 13,894 lacs on higher tax expense (MAT credit utilized Rs 1,345 lacs). Standalone PAT grew 12% to Rs 18,222 lacs. Company acquired controlling stakes in Axiom Ayurveda (Rs 200 cr deal) and IncNut Digital (Rs 320 cr, 60% stake) during the quarter. Auditor issued a qualified conclusion on consolidated results as some subsidiary financials were unreviewed. EBITDA margins compressed from about 26% to 23.5%.
Solid topline growth offset by margin compression and PAT dip. Acquisitions may boost future growth but carry integration risk. Auditor flagged unreviewed units.